Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma

[TimAlerts] KMPH 7.49float KemPharm Granted "Fast Track" Designation for KP201/IR http://finance.yahoo.com/news/biolife-solutions-executes-10-supply-110000414.html
Received 0 Karma
Received 0 Karma
Received 0 Karma

[TimAlerts] KMPH http://finance.yahoo.com/news/kempharm-receives-clearance-fda-initiate-113000624.html KemPharm Receives Clearance from FDA to Initiate Clinical Program for KP415, an Investigational Prodrug of D-Threo-Methylphenidate for the Treatment of ADHD
Received 0 Karma
Received 1 Karma